Advertisement

Topics

Humacyte, Inc. Company Profile

00:21 EST 14th December 2018 | BioPortfolio

Humacyte, Inc., a privately held company founded in 2004, is a medical research, discovery and development company with clinical and pre-clinical stage investigational products. Humacyte is primarily focused on developing and commercializing a proprietary novel technology based on human tissue-based products for key applications in regenerative medicine and vascular surgery. The company uses its innovative, proprietary platform technology to engineer human, extracellular matrix-based tissues that can be shaped into tubes, sheets, or particulate conformations, with properties similar to native tissues. These are being developed for potential use in many specific applications, with the goal to significantly improve treatment outcomes for many patients, including those with vascular disease and those requiring hemodialysis. The company’s proprietary technologies are designed to create off-the-shelf products that, once approved, can be utilized in any patient. The company web site is www.humacyte.com.


News Articles [10 Associated News Articles listed on BioPortfolio]

Humacyte Promotes Jeffrey Lawson to Chief Executive

Jeffrey Lawson has been appointed CEO of regenerative medicine company Humacyte. Lawson had been chief medical officer of the Research Triangle Park, NC, company since 2015. Lawson’s experience incl...

Fresenius Medical to invest $150M in Humacyte

Fresenius Medical Care will purchase a 19% fully diluted ownership stake in US tissue engineering company Humacyte for $150 m -More- 

Fresenius licenses Humacyte's Humacyl acellular vessel; makes $150mm investment

Humacyte Inc. granted Fresenius Medical Care AG & Co. KGAA exclusive global rights to commercialize the Humacyl human acellular vessel (HAV).

Phase II study begins for Humacyte's human acellular vessel

A US Phase II trial has been initiated by Humacyte to evaluate its Humacyl investigational human acellular vessel in vascular -More- 

Fresenius Medical Care to acquire 19% stake in Humacyte

Fresenius Medical Care has agreed to purchase a 19% stake in medical research, discovery and development firm, Humacyte, for around $150m.

Humacyte starts US phase II vascular trauma trial of Humacyl

Humacyl is an investigational human acellular vessel (HAV), which is being evaluated for vascular replacement or reconstruction in patients with life- or limb-threatening vascular trauma. The study, w...

Humacyte Appoints Doug Blankenship as Chief Financial Officer

Life Science Finance Executive Strengthens Management Team Humacyte, an innovator in biotechnology and regenerative medicine, announced today the appointment of Douglas L. Bla...

Humacyte Appoints Jeffrey Lawson MD, PhD as President and Chief Executive Officer

Long-time Chairman and CEO Carrie S. Cox Appointed Executive Chairman Humacyte, an innovator in biotechnology and regenerative medicine, announced today that Jeffrey Lawson MD...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Humacyte's HAV for Femoro-Popliteal Bypass in Patients With PAD

This study will evaluate how well Humacyte's Human Acellular Vessel (HAV) works when surgically implanted into a leg to improve blood flow in patients with peripheral arterial disease (PAD...

Humacyte Human Acellular Vessel (HAV) in Patients With Limb-threatening Peripheral Arterial Trauma

This study evaluates the use of the Human Acellular Vessel (HAV) in adults with arterial trauma in the lower limb who are undergoing vascular reconstructive surgery. All subjects will be i...

Companies [1 Associated Companies listed on BioPortfolio]

Humacyte, Inc.

Humacyte, Inc., a privately held company founded in 2004, is a medical research, discovery and development company with clinical and pre-clinical stage investigational products. H...

More Information about "Humacyte, Inc." on BioPortfolio

We have published hundreds of Humacyte, Inc. news stories on BioPortfolio along with dozens of Humacyte, Inc. Clinical Trials and PubMed Articles about Humacyte, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Humacyte, Inc. Companies in our database. You can also find out about relevant Humacyte, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...


Corporate Database Quicklinks



Searches Linking to this Company Record